Lataa...
Retinoic acid receptor antagonists for male contraception: current status(†)
Retinoic acid receptor alpha (RARA), a nuclear receptor protein, has been validated as a target for male contraception by gene knockout studies and also pharmacologically using a pan-retinoic acid receptor antagonist. Retinoic acid receptor alpha activity is indispensable for the spermatogenic proce...
Tallennettuna:
| Julkaisussa: | Biol Reprod |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7401398/ https://ncbi.nlm.nih.gov/pubmed/32671394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/biolre/ioaa122 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|